tiprankstipranks
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market
Want to see IN:SPARC full AI Analyst Report?

Sun Pharma Advanced Research Co. Ltd. (SPARC) Financial Statements

8 Followers

Sun Pharma Advanced Research Co. Ltd. Financial Overview

Sun Pharma Advanced Research Co. Ltd.'s market cap is currently ₹63.64B. The company's EPS TTM is ₹48.81; its P/E ratio is 4.02; Sun Pharma Advanced Research Co. Ltd. is scheduled to report earnings on August 10, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 18.79B₹ 717.70M₹ 755.45M₹ 2.39B₹ 1.37B
Gross Profit₹ 17.27B₹ 486.50M₹ -1.24B₹ 821.21M₹ 105.52M
Operating Income₹ 15.89B₹ -2.78B₹ -4.12B₹ -2.24B₹ -1.97B
EBITDA₹ 15.99B₹ -3.23B₹ -3.73B₹ -2.03B₹ -1.80B
Net Income₹ 15.53B₹ -3.43B₹ -3.87B₹ -2.23B₹ -2.03B
Balance Sheet
Cash & Short-Term Investments₹ 26.20M₹ 19.60M₹ 1.57B₹ 4.07B₹ 128.89M
Total Assets₹ 21.71B₹ 3.36B₹ 5.15B₹ 8.30B₹ 2.80B
Total Debt₹ 5.59B₹ 2.69B₹ 611.51M₹ 156.70M₹ 792.14M
Net Debt₹ 5.58B₹ 2.67B₹ 558.22M₹ 150.90M₹ 779.89M
Total Liabilities₹ 8.32B₹ 5.52B₹ 3.89B₹ 3.17B₹ 2.49B
Stockholders' Equity₹ 13.39B₹ -2.17B₹ 1.26B₹ 5.13B₹ 312.26M
Cash Flow
Free Cash Flow₹ -2.97B₹ -3.71B₹ -4.56B₹ -845.10M₹ -2.41B
Operating Cash Flow₹ -2.73B₹ -3.60B₹ -4.29B₹ -691.20M₹ -2.08B
Investing Cash Flow₹ -235.30M₹ 1.58B₹ 3.92B₹ -5.48B₹ -291.67M
Financing Cash Flow₹ 2.96B₹ 1.99B₹ 424.05M₹ 6.17B₹ 2.29B
Currency in INR

Sun Pharma Advanced Research Co. Ltd. Earnings and Revenue History

Sun Pharma Advanced Research Co. Ltd. Debt to Assets

Sun Pharma Advanced Research Co. Ltd. Cash Flow

Sun Pharma Advanced Research Co. Ltd. Forecast EPS vs Actual EPS